Senior Director, Corporate Development

Bausch + Lomb (NYSE/TSX: BLCO) is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth through every phase of life. Our mission is simple, yet powerful: helping you see better, to live better.

Our comprehensive portfolio of over 400 products is fully integrated and built to serve our customers across the full spectrum of their eye health needs throughout their lives. Our iconic brand is built on the deep trust and loyalty of our customers established over our 170-year history. We have a significant global research, development, manufacturing and commercial footprint of approximately 13,000 employees and a presence in approximately 100 countries, extending our reach to billions of potential customers across the globe. We have long been associated with many of the most significant advances in eye health, and we believe we are well positioned to continue leading the advancement of eye health in the future.

Overview:

We are seeking an exceptional senior Director of Corporate Development to join us at a pivotal moment of growth and transformation. Reporting directly to the SVP, Business Development & Corporate Strategy, you will be instrumental in shaping the future of eye health by developing strategic initiatives, identifying and executing on business development and M&A opportunities and evaluating partnerships. The successful candidate will have a deep understanding of business and market dynamics, transactions and partnerships, a track record of developing and executing successful corporate strategies, robust understanding of finance, and the ability to work collaboratively with cross-functional teams.

Responsibilities:

• Collaborate with the SVP Business Development & Corporate Strategy to create and execute long-range strategic plans that align with the organization's vision, mission, and goals

• Source, evaluate and execute M&A opportunities, strategic partnerships, and licensing agreements that help us accelerate innovation and bring new products in eye health

• Lead end-to-end transaction processes including target identification, due diligence, valuation, deal structuring, and preparing handover for post-merger integration activities and in some cases, retaining ongoing alliance management responsibilities for structured partnerships and licensing arrangements where full integration is not the model.

• Build sophisticated financial models and business cases to evaluate investment opportunities, quantify strategic value creation, and support executive decision making

• Manage external advisors including investment banks, consulting firms and legal counsel during transaction processes

• Assess portfolio optimization opportunities including strategic divestitures and asset rationalization to focus resources on highest value initiatives